Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 7603975, 10 pages
http://dx.doi.org/10.1155/2016/7603975
Research Article

Improvement of Electroacupuncture on APP/PS1 Transgenic Mice in Spatial Learning and Memory Probably due to Expression of Aβ and LRP1 in Hippocampus

1School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, No. 11 Bei San Huan Dong Lu, Chaoyang District, Beijing 100029, China
2Community Health Service Administration Center of Dongcheng District, No. 192-1 Chaoyangmen Internal Street, Dongcheng District, Beijing 100053, China

Received 3 June 2016; Revised 22 August 2016; Accepted 5 September 2016

Academic Editor: Genevieve Steiner

Copyright © 2016 Xin Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Citron, “Alzheimer's disease: Strategies for disease modification,” Nature Reviews Drug Discovery, vol. 9, no. 5, pp. 387–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Goedert and M. G. Spillantini, “A century of Alzheimer's disease,” Science, vol. 314, no. 5800, pp. 777–781, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Hampel, D. Prvulovic, S. Teipel et al., “The future of Alzheimer's disease: the next 10 years,” Progress in Neurobiology, vol. 95, no. 4, pp. 718–728, 2011. View at Publisher · View at Google Scholar
  4. M. C. Cárdenas-Aguayo, M. C. Silva-Lucero, M. Cortes-Ortiz et al., “Physiological role of amyloid beta in neural cells: the cellular trophic activity,” in Neurochemistry, T. Heinbockel, Ed., pp. 401–407, InTech, Rijeka, Croatia, 2014. View at Publisher · View at Google Scholar
  5. B. V. Zlokovic, “Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders,” Nature Reviews Neuroscience, vol. 12, no. 12, pp. X723–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. W. Bero, P. Yan, J. H. Roh et al., “Neuronal activity regulates the regional vulnerability to amyloid-β 2 deposition,” Nature Neuroscience, vol. 14, no. 6, pp. 750–756, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-C. Chang, J. C. Althaus, C. J. L. Carruthers, M. A. Sutton, D. G. Steel, and A. Gafni, “Synergistic interactions between Alzheimer's Aβ40 and Aβ42 on the surface of primary neurons revealed by single molecule microscopy,” PLoS ONE, vol. 8, no. 12, Article ID e82139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Musiek and D. M. Holtzman, “Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’,” Nature Neuroscience, vol. 18, no. 6, pp. 800–806, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. K. G. Mawuenyega, W. Sigurdson, V. Ovod et al., “Decreased clearance of CNS β-amyloid in Alzheimer's disease,” Science, vol. 330, no. 6012, p. 1774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. D. Bell and B. V. Zlokovic, “Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease,” Acta Neuropathologica, vol. 118, no. 1, pp. 103–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. V. Zlokovic, “The blood-brain barrier in health and chronic neurodegenerative disorders,” Neuron, vol. 57, no. 2, pp. 178–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. V. Zlokovic, “Neurodegeneration and the neurovascular unit,” Nature Medicine, vol. 16, no. 12, pp. 1370–1371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. V. Zlokovic, R. Deane, A. P. Sagare, R. D. Bell, and E. A. Winkler, “Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain,” Journal of Neurochemistry, vol. 115, no. 5, pp. 1077–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. D. Hayes, D. Dey, J. P. Palavicini, H. Wang, W. Araki, and M. K. Lakshmana, “Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice,” PLoS ONE, vol. 7, no. 10, Article ID e45841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Xie and Z. Xu, “General anesthetics and β-amyloid protein,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 47, pp. 140–146, 2013. View at Publisher · View at Google Scholar
  16. T. Kanekiyo and G. Bu, “The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease,” Frontiers in Aging Neuroscience, vol. 6, article 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yamada, T. Hashimoto, C. Yabuki et al., “The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid β peptides in an in vitro model of the blood-brain barrier cells,” Journal of Biological Chemistry, vol. 283, no. 50, pp. 34554–34562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. D. Bell, A. P. Sagare, A. E. Friedman et al., “Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 5, pp. 909–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Donahue, S. L. Flaherty, C. E. Johanson et al., “RAGE, LRP-1, and amyloid-β protein in Alzheimer's disease,” Acta Neuropathologica, vol. 112, no. 4, pp. 405–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Zhao, A. P. Sagare, Q. Y. Ma et al., “Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance,” Nature Neuroscience, vol. 18, no. 7, pp. 978–987, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Ying, Effect of acupuncture on behavioral and psychological symptoms in Alzheimer's disease [Ph.D. thesis], Chendu University of TCM, 2006.
  22. C. T. Zhao, Clincal trial of ‘Guixue’ acupuncture on behavior and psychological symptoms of dementia: phase I [Ph.D. dissertation], Chengdu University of TCM, Chengdu, China, 2011.
  23. Q. H. Guo, Q. T. Jie, and T. S. Shan Ben, “The effects of acupuncture in treating behaviors associated with psychological symptoms of dementia in Alzheimer's disease: three cases,” Japanese Journal of Geriatric Psychiatry, vol. 21, pp. 456–463, 2010. View at Google Scholar
  24. S. Feng, Q. Wang, H. Wang et al., “Electroacupuncture pretreatment ameliorates hypergravity-induced impairment of learning and memory and apoptosis of hippocampal neurons in rats,” Neuroscience Letters, vol. 478, no. 3, pp. 150–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Wang, H. Zhong, X. Li et al., “Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice,” Molecular Neurobiology, vol. 50, no. 2, pp. 305–313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Li, F. Guo, Q. Zhang et al., “Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice,” BMC Complementary and Alternative Medicine, vol. 14, article 37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. G. Dong, W. Q. Guo, X. H. Zheng et al., “Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice,” Metabolic Brain Disease, vol. 30, no. 3, pp. 777–784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Yang, L. Yang, and X. Gao, “Transcutaneous electrical nerve stimulation on Yongquan acupoint reduces CFA-induced thermal hyperalgesia of rats via down-regulation of ERK2 phosphorylation and c-Fos expression,” Anatomical Record, vol. 293, no. 7, pp. 1207–1213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T. T. Tian, Q. Li, Y. L. Zhang, and Y. W. Cui, “Clinical observation of ‘awaking and tonifying the brain’ acupuncture in treating on senile dementia,” Jilin Journal of Traditional Chinese Medicine, vol. 4, pp. 404–405, 2012. View at Google Scholar
  30. R. Minkeviciene, J. Ihalainen, T. Malm et al., “Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice,” Journal of Neurochemistry, vol. 105, no. 3, pp. 584–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. L. Alonso, S. P. Merino, S. Gonzalez, and J. Defelipe, “Synaptic changes in the dentate gyrus of APP/PS1 transgenic mice revealed by electron microscopy,” Journal of Neuropathology and Experimental Neurology, vol. 72, no. 5, pp. 386–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. P. Sagare, R. Deane, and B. V. Zlokovic, “Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities,” Pharmacology and Therapeutics, vol. 136, no. 1, pp. 94–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Hong, O. Quintero-Monzon, B. L. Ostaszewski et al., “Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in isf versus parenchymal aβ during age-related plaque formation,” The Journal of Neuroscience, vol. 31, no. 44, pp. 15861–15869, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Kanekiyo, C.-C. Liu, M. Shinohara, J. Li, and G. Bu, “LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β,” Journal of Neuroscience, vol. 32, no. 46, pp. 16458–16465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Narita, D. M. Holtzman, A. L. Schwartz, and G. Bu, “α2-macroglobulin complexes with and mediates the endocytosis of β- amyloid peptide via cell surface low-density lipoprotein receptor-related protein,” Journal of Neurochemistry, vol. 69, no. 5, pp. 1904–1911, 1997. View at Google Scholar · View at Scopus
  36. C. V. Zerbinatti, S. E. Wahrle, H. Kim et al., “Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aβ42 accumulation in amyloid model mice,” Journal of Biological Chemistry, vol. 281, no. 47, pp. 36180–36186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. P. G. Ulery, J. Beers, I. Mikhailenko et al., “Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease,” Journal of Biological Chemistry, vol. 275, no. 10, pp. 7410–7415, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. V. Zerbinatti, D. F. Wozniak, J. Cirrito et al., “Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 4, pp. 1075–1080, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. K. K. Kandimalla, G. L. Curran, S. S. Holasek, E. J. Gilles, T. M. Wengenack, and J. F. Poduslo, “Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid β protein 40 in wild-type and alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 3, pp. 1370–1378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Grimmer, O. Goldhardt, L.-H. Guo et al., “LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo,” NeuroImage: Clinical, vol. 4, pp. 411–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. J. R. Cirrito, P. C. May, M. A. O'Dell et al., “In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life,” Journal of Neuroscience, vol. 23, no. 26, pp. 8844–8853, 2003. View at Google Scholar · View at Scopus
  42. R. Deane, Z. Wu, A. Sagare et al., “LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms,” Neuron, vol. 43, no. 3, pp. 333–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. W.-G. Xue, Z. Zhang, H. Xu, H.-X. Wu, and L.-M. Bai, “Effect of electroacupuncture on learning-memory ability, and Abeta and LRP1 immunoactivity in hippocampal sulcus microvessels in APP transgenic mice,” Acupuncture Research, vol. 36, no. 2, pp. 95–100, 2011. View at Google Scholar · View at Scopus
  44. Y. Liu, L. Gao, N. H. Lin et al., “Effect of the pathology senile plaques in cerebral cortex on the learning and memory abilities of the APP/PS1 double transgenic mice,” Chinese Journal of Neuroanatomy, vol. 23, no. 3, pp. 225–231, 2007. View at Google Scholar
  45. W. A. Jia, X. Wang, and L. I. Fu, “The effect of electro-acupuncture at Baihui and Yongquan on the hippocampus ultrastructure in APP/PS1 double transgenic mice,” Global Traditional Chinese Medicine, vol. 4, pp. 389–394, 2015. View at Google Scholar
  46. T. Kanekiyo, J. R. Cirrito, C.-C. Liu et al., “Neuronal clearance of amyloid-β by endocytic receptor LRP1,” Journal of Neuroscience, vol. 33, no. 49, pp. 19276–19283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. E. Roher, D. H. Cribbs, R. C. Kim et al., “Bapineuzumab alters Aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy,” PLoS ONE, vol. 8, no. 3, article e59735, 2013. View at Publisher · View at Google Scholar · View at Scopus